SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 20th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and Hall Family Trust dated 7/21/2003 (“Purchaser”) a person whose address is 5019 Tierra Del Oro Carlsbad CA.
AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS INC. AND DAVID CHERESHAgreement by And • April 19th, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
Agreement made on April 17th, 2019 (“Execution Date”) by and between David Cheresh (“Scientific Advisory Board Member” also referred to as “SAB Member”), a natural person whose address is at ________________________________ and Zander Therapeutics Inc. (“Company”), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. SAB Member and Company may be referred to individually as “Party” and collectively as “Parties”.
AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND THOMAS DONNELLYAgreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
Agreement made on August 7, 2017 ("Execution Date") by and between Thomas Donnelly ("Consultant"), a natural person whose address is at 44 Rue Bourgelat, 94700 Maisons-Alfort, FRANCE and Zander Therapeutics, Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as "Party" and collectively as "Parties".
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. AND Todd S. CavenEmployment Agreement • September 26th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 21, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Todd S. Caven ("Employee").
ContractBusiness Advisory Board Services Agreement • April 12th, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
This Business Advisory Board Services Agreement (the “Agreement”) is entered into between Zander Therapeutics, Inc., a Nevada corporation (“the Company), and John Lazor, an individual with a principal place of residence _________(“Candidate”).
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.Agreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of June 23, 2015 (the “Effective Date”), is made and entered into by and between Regen BioPharma Inc., an Nevada corporation (“Licensor”) and Zander Therapeutics Inc., a Nevada corporation (“Licensee”). Licensor and Licensee may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. AND Harry M. Lander, Ph.D., M.B.A.Employment Agreement • September 26th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 5, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Harry M. Lander ("Employee").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS SECURITIES PURCHASE AGREEMENT (the ''Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the (“Company'') whose address is
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated December 15, 2017Agreement by And • January 16th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF ANY AND ALL INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. AND David R. KoosEmployment Agreement • September 26th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of June 19, 2018 is entered into between Zander Therapeutics, Inc., a Nevada corporation, (the "Company") and David R. Koos
AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND HARRY LANDERAgreement by And • January 25th, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
Agreement made on made on January 23, 2019 by and between Harry Lander (“Consultant”), a natural person whose address is at 36 Robinson Rd, #13-0, Singapore and Zander Therapeutics, Inc. (“Company”), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as “Party” and collectively as “Parties”.
COLLABORATION AND DEVELOPMENT AgreementCollaboration and Development Agreement • July 10th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
This Collaboration Agreement (“Agreement”) is made as of July 5, 2018 (the “Effective Date”) by and between Ampersand Biopharmaceuticals, Inc, a Delaware corporation with offices located at 2545 W. Hillcrest Dr., Thousand Oaks, CA 91320 (“Ampersand”), and Zander Therapeutics, Inc. a Nevada corporation, with offices located at 4700 Spring Street, Suite 304 La Mesa, CA, 91942, USA (“Zander”). Ampersand and Zander are sometimes referred to in this Agreement individually as a “Party”, and collectively as the “Parties”.
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated September 12, 2017Agreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
ContractAgreement • October 4th, 2017 • Zander Therapeutics, Inc • California
Agreement made on March 20, 2017 (“Execution Date”) by and between Linda Black (“Consultant”), a natural person whose address is ___________and Entest BioMedical Inc.
SECURITIES PURCHASE AGREEMENT ZANDER THERAPEUTICS, INC.Securities Purchase Agreement Zander Therapeutics • September 26th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the "Company") whose address is 4700 Spring Street, St 304, La Mesa, California 91942, and ______________("Purchaser '), a trust whose address is____________________.
AMENDED AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND JONATHAN BAELLAmended Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
Agreement made on August 16, 2017 ("Execution Date") by and between Jonathan Baell ("Consultant"), a natural person whose address is at 53 Glenard Drive, Eaglemont, VICTORIA 3084 Australia and Zander Therapeutics, Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as "Party" and collectively as "Parties".
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated June 15, 2016Agreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
PRIVATE PLACEMENT AGENT AGREEMENTPrivate Placement Agent Agreement • June 15th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • New York
THIS PRIVATE PLACEMENT AGENT AGREEMENT (the “Agreement”) is made and entered into as of the 12th day of June , 2018, by and between Zander Therapeutics, Inc. (the “Company”), and Dakoy Capital Markets, LLC (the “Placement Agent”).
SECURITIES PURCHASE AGREEMENT ZANDER THERAPEUTICS, INC.Securities Purchase Agreement • September 26th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the "Company") whose address is 4700 Spring Street, St 304, La Mesa, California 91942, and ______________("Purchaser '), a trust whose address is____________________.
SECURITIES PURCHASE AGREEMENT ZANDER THERAPEUTICS, INC.Securities Purchase Agreement • September 26th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the "Company") whose address is 4700 Spring Street, St 304, La Me California 91942, and Herrick Family Trust ("Purchaser"), a person whose address is (5022 Royal Vista Court, Westlake Village, CA 91362)
CONSULTING FEE AGREEMENTConsulting Fee Agreement • May 31st, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations
Consultant has a relationship with various individuals and entities which have the ability to provide the Financing ( each a "Source," and collectively, the "Sources") and is willing to provide introductions of Sources to Client and Client desires to have Consultant provided such introductions.
SUBLEASE AGREEMENTSublease Agreement • November 20th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations
This is an agreement to sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 according to the terms specified below.
ContractBusiness Advisory Board Services Agreement • September 26th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
This Business Advisory Board Services Agreement (the "Agreement"), dated July 23, 2018, is entered into between Zander Therapeutics Inc., a Nevada corporation ("the Company"), and Joey Herrick, an individual with a principal place of residence of 5022 Royal Vista Court, Westlake Village, CA 91362 ("Candidate").
ContractAgreement • December 18th, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
Agreement by and between Zander Therapeutics, Inc. (“Zander”), KCL Therapeutics, Inc. (“KCL”) and Regen BioPharma, Inc. (“Regen”) as of December 16, 2019. For purposes of this Agreement Regen and KCL may be also referred to singularly or collectively as “Licensor”. For purposes of this Agreement Regen, KCL and Zander may be collectively referred to as the “Parties” or individually as a “Party”. The effective date of this Agreement is December 16, 2019.
AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. ("ZANDER") AND ENTESTAgreement by and Between Zander • October 4th, 2017 • Zander Therapeutics, Inc
WHEREAS ENTEST paid $1,115 of incorporation expenses incurred in the incorporation of ZANDER on June 18, 2015("lncorporation Expenses")
SUBLEASE AGREEMENTSublease Agreement • July 10th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations
This is an agreement to sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 according to the terms specified below.
ContractAgreement • September 18th, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations • Minnesota
This agreement (the “Agreement”), dated as of September 17, 2019, by and between Zander Therapeutics, Inc., a Nevada corporation, with headquarters located at 4700 Spring Street, Suite 304, La Mesa, CA 91942 (“Zander”) and Klinton A. Klaas, a Minnesota resident located at 9927 Park Crossing, Woodbury, MN 55125 (“Klaas”).
ADVISORY AGREEMENTAdvisory Agreement • June 15th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • New York
THIS ADVISORY AGREEMENT (the "Agreement") is made and entered into as of the 12th day of June, 2018, by and between Zander Therapeutics, Inc. (the "Company"), and Dakoy Capital Markets, LLC, a member in good standing of the Financial Industry Regulatory Authority (the "Advisor").
AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS INC. AND JUDITH A VARNERAgreement by and Between Zander • April 26th, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
Agreement made on April 24th, 2019 (“Execution Date”) by and between Judith A Varner (“Scientific Advisory Board Member” also referred to as “SAB Member”), a natural person whose address is at ________________________________ and Zander Therapeutics Inc. (“Company”), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. SAB Member and Company may be referred to individually as “Party” and collectively as “Parties”.
ContractSecurities Purchase Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”), a _______ whose address is _____________.
INTELLECTUAL PROPERTY LICENSE AGREEMENTIntellectual Property License Agreement • January 24th, 2019 • Zander Therapeutics, Inc • Pharmaceutical preparations • Victoria
MONASH UNIVERSITY [ABN 12 377 614 012] a body corporate established pursuant to the Monash University Act 1958 (Victoria), of Wellington Road, Clayton, Victoria 3800, Australia (“Monash”).
